(IMMR) Immersion - Overview
Stock: Haptic Software, Automotive, Medical, Gaming
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.04% |
| Yield on Cost 5y | 1.48% |
| Yield CAGR 5y | 77.95% |
| Payout Consistency | 100.0% |
| Payout Ratio | 30.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.1% |
| Relative Tail Risk | -9.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -33.08 |
| Character TTM | |
|---|---|
| Beta | 1.036 |
| Beta Downside | 0.921 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.70% |
| CAGR/Max DD | 0.02 |
Description: IMMR Immersion December 31, 2025
Immersion Corporation (NASDAQ:IMMR) is a Florida-based IP licensor that monetizes its patented haptic-technology patents across a broad set of end-markets-including mobile devices, wearables, console gaming, automotive, medical and commercial applications. The company’s revenue model combines licensing fees, royalty payments, and ancillary services such as software integration tools, technical support, and textbook-related merchandising and distribution.
Key industry data points that shape Immersion’s outlook: (1) the global haptics market is projected to grow at a compound annual growth rate of roughly 15 % through 2029, driven by demand for richer user experiences in smartphones and VR/AR devices; (2) licensing revenue historically accounts for about 80 % of Immersion’s total sales, with the remaining 20 % coming from services and merchandise-an allocation that can amplify earnings volatility when major OEM contracts are renegotiated; (3) recent quarterly filings (Q3 2024) showed a 12 % YoY increase in royalty receipts, reflecting new partnerships with automotive OEMs expanding into tactile feedback for driver-assist interfaces. These trends suggest that macro-level adoption of haptic feedback and the firm’s ability to secure long-term licensing agreements are primary drivers of future earnings.
For a deeper quantitative view of IMMR’s valuation metrics, the ValueRay platform offers a concise analyst dashboard that can help you assess the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 90.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -15.82 > 1.0 |
| NWC/Revenue: 31.38% < 20% (prev 451.5%; Δ -420.1% < -1%) |
| CFO/TA -0.06 > 3% & CFO -77.8m > Net Income 90.2m |
| Net Debt (244.5m) to EBITDA (177.2m): 1.38 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.1m) vs 12m ago 1.06% < -2% |
| Gross Margin: 29.08% > 18% (prev 0.99%; Δ 2809 % > 0.5%) |
| Asset Turnover: 155.6% > 50% (prev 15.72%; Δ 139.9% > 0%) |
| Interest Coverage Ratio: 16.19 > 6 (EBITDA TTM 177.2m / Interest Expense TTM 9.62m) |
Altman Z'' 3.33
| A: 0.28 (Total Current Assets 926.0m - Total Current Liabilities 538.6m) / Total Assets 1.37b |
| B: 0.03 (Retained Earnings 41.7m / Total Assets 1.37b) |
| C: 0.20 (EBIT TTM 155.6m / Avg Total Assets 793.1m) |
| D: 0.05 (Book Value of Equity 43.7m / Total Liabilities 804.2m) |
| Altman-Z'' Score: 3.33 = A |
Beneish M 1.00
| DSRI: 1.01 (Receivables 365.1m/9.98m, Revenue 1.23b/33.9m) |
| GMI: 3.40 (GM 29.08% / 98.97%) |
| AQI: 0.71 (AQ_t 0.14 / AQ_t-1 0.20) |
| SGI: 36.39 (Revenue 1.23b / 33.9m) |
| TATA: 0.12 (NI 90.2m - CFO -77.8m) / TA 1.37b) |
| Beneish M-Score: 24.48 (Cap -4..+1) = D |
What is the price of IMMR shares?
Over the past week, the price has changed by -0.60%, over one month by +4.12%, over three months by -1.57% and over the past year by -18.21%.
Is IMMR a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IMMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 102.1% |
| Analysts Target Price | 13.5 | 102.1% |
| ValueRay Target Price | 6.9 | 3.1% |
IMMR Fundamental Data Overview February 03, 2026
P/E Forward = 16.0514
P/S = 1.3543
P/B = 0.6932
P/EG = -0.45
Revenue TTM = 1.23b USD
EBIT TTM = 155.6m USD
EBITDA TTM = 177.2m USD
Long Term Debt = 141.2m USD (from longTermDebt, last quarter)
Short Term Debt = 74.5m USD (from shortTermDebt, last quarter)
Debt = 322.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 244.5m USD (from netDebt column, last quarter)
Enterprise Value = 384.4m USD (216.1m + Debt 322.1m - CCE 153.9m)
Interest Coverage Ratio = 16.19 (Ebit TTM 155.6m / Interest Expense TTM 9.62m)
EV/FCF = -4.47x (Enterprise Value 384.4m / FCF TTM -85.9m)
FCF Yield = -22.35% (FCF TTM -85.9m / Enterprise Value 384.4m)
FCF Margin = -6.96% (FCF TTM -85.9m / Revenue TTM 1.23b)
Net Margin = 7.31% (Net Income TTM 90.2m / Revenue TTM 1.23b)
Gross Margin = 29.08% ((Revenue TTM 1.23b - Cost of Revenue TTM 875.3m) / Revenue TTM)
Gross Margin QoQ = 22.29% (prev 24.46%)
Tobins Q-Ratio = 0.28 (Enterprise Value 384.4m / Total Assets 1.37b)
Interest Expense / Debt = 1.29% (Interest Expense 4.17m / Debt 322.1m)
Taxrate = 47.27% (17.4m / 36.8m)
NOPAT = 82.1m (EBIT 155.6m * (1 - 47.27%))
Current Ratio = 1.72 (Total Current Assets 926.0m / Total Current Liabilities 538.6m)
Debt / Equity = 1.01 (Debt 322.1m / totalStockholderEquity, last quarter 319.2m)
Debt / EBITDA = 1.38 (Net Debt 244.5m / EBITDA 177.2m)
Debt / FCF = -2.85 (negative FCF - burning cash) (Net Debt 244.5m / FCF TTM -85.9m)
Total Stockholder Equity = 265.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.38% (Net Income 90.2m / Total Assets 1.37b)
RoE = 33.99% (Net Income TTM 90.2m / Total Stockholder Equity 265.4m)
RoCE = 38.27% (EBIT 155.6m / Capital Employed (Equity 265.4m + L.T.Debt 141.2m))
RoIC = 20.94% (NOPAT 82.1m / Invested Capital 391.8m)
WACC = 4.32% (E(216.1m)/V(538.3m) * Re(9.73%) + D(322.1m)/V(538.3m) * Rd(1.29%) * (1-Tc(0.47)))
Discount Rate = 9.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.45%
Fair Price DCF = unknown (Cash Flow -85.9m)
EPS Correlation: 0.59 | EPS CAGR: -32.83% | SUE: -0.49 | # QB: 0
Revenue Correlation: 75.41 | Revenue CAGR: 206.0% | SUE: 4.0 | # QB: 3
EPS next Year (2026-04-30): EPS=0.42 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-76.9% | Growth Revenue=+5.2%